D C Hanson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D C Hanson

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Neuron|November 1, 1995

Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxinsJ Aiyar, J M Withka, J P Rizzi, et al.

Molecular Pharmacology|June 1, 1994

Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell linesS Grissmer, A N Nguyen, J Aiyar, et al.

Journal of Medicinal Chemistry|April 14, 1995

The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressantK Koch, M F Newborg, D C Hanson, et al.

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995

CP-123,369: a potent, orally active immunosuppressive agentK Koch, D C Hanson, M F Newborg, et al.

Molecular Pharmacology|December 1, 1996

Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activationA Nguyen, J C Kath, D C Hanson, et al.

British Journal of Pharmacology|June 18, 1999

UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Neuron|November 1, 1995

Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxinsJ Aiyar, J M Withka, J P Rizzi, et al.

Molecular Pharmacology|June 1, 1994

Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell linesS Grissmer, A N Nguyen, J Aiyar, et al.

Journal of Medicinal Chemistry|April 14, 1995

The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressantK Koch, M F Newborg, D C Hanson, et al.

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995

CP-123,369: a potent, orally active immunosuppressive agentK Koch, D C Hanson, M F Newborg, et al.

Molecular Pharmacology|December 1, 1996

Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activationA Nguyen, J C Kath, D C Hanson, et al.

British Journal of Pharmacology|June 18, 1999

UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.

Pageof 3